Riskpilot← Back to searchSign inGet full accessNOBEL BIOCARE DANMARK A/S
A/SActiveCVR 28293364Sindbjergvej 3AManufacture of medical and dental instruments and supplies · NACE 3250Est. 20043 employees
Revenue 2024
DKK 3,8M
+21% vs 2023
EBITDA margin
7.9%
+5% vs 2023
Equity ratio
-3.8%
Financial strength
Net profit 2024
DKK -4,5M
-123% vs 2023
| Revenue | DKK 3,8M | +21% |
| EBITDA | DKK 300K | +5% |
| Net profit | DKK -4,5M | -123% |
| Total assets | DKK 160M | +4% |
| Equity | DKK -6,1M | -273% |
| Employees | 3 | — |
Legal name
NOBEL BIOCARE DANMARK A/S
CVR number
28293364
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
24. november 2004
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er udvikling, fabrikation og salg af lægemidler og andre produkter til helse- og sundhedspleje samt kemisk-tekniske artikler, at drive medicinsk-teknisk virksomhed og anden dermed forbunden virksomhed samt at eje og forvalte fast ejendom og løsøre.
Address
Sindbjergvej 3A
Phone
+4539404846
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.081 | 5.278 | 5.214 | 5.513 | 6.274 | 3.775 | 3.337 | 3.951 | 4.787 | 4.268 | 3.338 | 3.123 | 3.773 |
| Staff expenses | -5.493 | -4.860 | -4.624 | -4.747 | -4.953 | -2.923 | -2.599 | -3.423 | -4.672 | -3.344 | -3.281 | -2.837 | -3.473 |
| EBITDA | 588 | 418 | 590 | 766 | 1.321 | 852 | 737 | 529 | 115 | 924 | 57 | 286 | 300 |
| Depreciation & amort. | -24 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 564 | 418 | 590 | 766 | 1.321 | 852 | 737 | 529 | 115 | 924 | 57 | 286 | 300 |
| Net financials | -10 | -8 | -12 | -4 | -168 | -102 | -195 | -6.101 | -1.055 | -590 | -642 | -2.838 | -5.261 |
| Profit before tax | 554 | 410 | 578 | 762 | 1.153 | 750 | 542 | -5.572 | -940 | 334 | -585 | -2.552 | -4.961 |
| Tax | 145 | 111 | 148 | 184 | 259 | 170 | 122 | -101 | -146 | 66 | -96 | -539 | -465 |
| Net profit | 409 | 299 | 430 | 578 | 894 | 580 | 420 | -5.471 | -794 | 268 | -489 | -2.013 | -4.497 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.506 | 5.043 | 4.914 | 6.735 | 23.794 | 23.857 | 24.673 | 383.694 | 121.202 | 62.220 | 60.969 | 154.529 | 160.037 |
| Equity | 4.655 | 1.954 | 2.383 | 2.961 | 3.855 | 4.435 | 4.855 | -616 | -1.410 | 858 | 369 | -1.644 | -6.141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 163 | 484 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.851 | 3.089 | 2.530 | 3.774 | 19.939 | 19.422 | 19.818 | 384.147 | 122.128 | 61.360 | 60.600 | 156.173 | 166.178 |
| Total debt | 3.851 | 3.089 | 2.530 | 3.774 | 19.939 | 19.422 | 19.818 | 384.310 | 122.612 | 61.360 | 60.600 | 156.173 | 166.178 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20122024
Equity ratio
-3.8%
This company
38.2%
Market median
-110% vs market
20122024
Return on equity
-449685400.0%
This company
18.4%
Market median
-2443942491% vs market
20122024
Net profit margin
-119.2%
This company
8.1%
Market median
-1572% vs market
20122024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20122024
Debt / equity
27.06×
This company
0.62×
Market median
-4265% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LF Management | Management | 2020 | — | — |
SW Management | Management | 2007 | — | — |
KO Management | Management | 2006 | — | — |
NT Management | Management | 2005 | — | — |
KM Management | Management | 2004 | — | — |
JH Management | Management | 2018 | — | — |
NB Founder | Founder | 2004 | — | — |
HB Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2007 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2005 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOBEL BIOCARE DANMARK A/S 
SCANORTO A/SBoard members of NOBEL BIOCARE DANMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Fredrik Strömberg | Management | 0 companies |
| Sven Wissing Jensen | Management | 0 companies |
| Kjell Ove Jonsson | Management | 0 companies |
| Nils Thomas Göran Nortoft | Management | 0 companies |
| Karl Magnus Persson | Management | 0 companies |
| Jens Henrik Nedoh | Management | 0 companies |
| Nobel Biocare Norden AB | Founder | 0 companies |
| Hans Braunstein | Management | 0 companies |
| Hans Tobias Nordefjäll | Board of Directors | 0 companies |
| Magnus K. Andreas Pettersson | Chairman | 0 companies |
| Harrieth Eva Elisabeth Sundaeus | Board of Directors | 0 companies |
| Karl Magnus Persson | Board of Directors | 0 companies |
| Alexander Johannes Ochsner | Board of Directors | 0 companies |
| Stefan Fabian Lieb | Board of Directors | 0 companies |
| Thomas Fritz Bögli | Board of Directors | 0 companies |
| Åsa Camilla Elisabeth Johnson | Chairman | 0 companies |
| Peter Esbjörn Rådqvist | Board of Directors | 0 companies |
| Barbro Michaela Ahlberg | Chairman | 0 companies |
| Lars Fredrik Strömberg | Board of Directors | 0 companies |
| Magnus Karl Andreas Pettersson | Chairman | 0 companies |
| Chris James Stahle | Board of Directors | 0 companies |
| Harrieth Eva Elisabeth Sundaeus | Board of Directors | 0 companies |
| Jacques Claude Gutedel | Board of Directors | 0 companies |
| Jan Jerne | Board of Directors | 0 companies |
| Jan Lars Robert Gottlander | Board of Directors | 0 companies |